In the last trading session, 1.9 million shares of the Definitive Healthcare Corp (NASDAQ:DH) were traded, and its beta was 1.43. Most recently the company’s share price was $5.35, and it changed around $0.2 or 3.88% from the last close, which brings the market valuation of the company to $828.80M. DH currently trades at a discount to its 52-week high of $10.62, offering almost -98.5% off that amount. The share price’s 52-week low was $3.19, which indicates that the current value has risen by an impressive 40.37% since then. We note from Definitive Healthcare Corp’s average daily trading volume that its 10-day average is 0.67 million shares, with the 3-month average coming to 593.33K.
Definitive Healthcare Corp stock received a consensus recommendation rating of Hold, based on a mean score of 2.71. If we narrow it down even further, the data shows that 0 out of 14 analysts rate the stock as a Sell; another 0 rate it as Overweight. Among the rest, 8 recommended DH as a Hold, whereas 4 deemed it a Buy, and 2 rated it as Underweight. Definitive Healthcare Corp is expected to report earnings per share of 0.07 for the current quarter.
Definitive Healthcare Corp (NASDAQ:DH) trade information
Instantly DH has showed a green trend with a performance of 3.88% at the end of last trading. The performance over the last five days has remained in the green territory. The rise to weekly highs of 5.55 on recent trading dayincreased the stock’s daily price by 3.6%. The company’s shares are currently up 30.17% year-to-date, but still up 12.63% over the last five days. On the other hand, Definitive Healthcare Corp (NASDAQ:DH) is 26.48% up in the 30-day period. We can see from the shorts that 2.1 million shares have been sold at a short interest cover period of 5.53 day(s).
The consensus price target as assigned by Wall Street analysts is $7, which translates to bulls needing to increase their stock price by 23.57% from its current value. Analyst projections state that DH is forecast to be at a low of $7 and a high of $7.
Definitive Healthcare Corp (DH) estimates and forecasts
The year-over-year growth rate is expected to be -0.38%, down from the previous year.
Consensus estimates provided by 12 financial analysts predict the company will bring in an average of 60.59M in revenue for the current quarter. 8 analysts expect Definitive Healthcare Corp to make 59.95M in revenue for the current ending quarter. The company’s sales for the same quarters a year ago were 65.93M and 63.48M respectively. Analysts predict that the company’s current quarter sales will drop, forecast at -8.10%. Forecasts for the next quarter put sales growth at -5.55%.
Looking at the company’s year-over-year earnings, the past five years showed a negative earnings growth rate of -64.67%. Definitive Healthcare Corp earnings are expected to increase by 14.56% in 2025, but the outlook is positive 2.83% per year for the next five years.
DH Dividends
Definitive Healthcare Corp’s next quarterly earnings report is expected to be released in March.
Definitive Healthcare Corp (NASDAQ:DH)’s Major holders
Upon looking at major shareholders, it appears that insiders hold 3.94% of Definitive Healthcare Corp shares, and 94.59% of them are in the hands of institutional investors. The stock currently has a share float of 98.47%. Definitive Healthcare Corp stock is held by 179.0 institutions, with ADVENT INTERNATIONAL CORP/MA being the largest institutional investor. By 2024-06-30, it held 53.2162% of the shares, which is about 62.49 million shares worth $341.22 million.
VANGUARD GROUP INC, with 3.9712% or 4.66 million shares worth $25.46 million as of 2024-06-30, holds the second largest percentage of outstanding shares.
MFS New Discovery Fund and iShares Russell 2000 ETF were the top two Mutual Funds as of Nov 30, 2024 . The former held 3.7 shares worth $19.78 million, making up 3.20% of all outstanding shares. On the other hand, iShares Russell 2000 ETF held roughly 1.52 shares worth around $8.13 million, which represents about 1.32% of the total shares outstanding.
